Gilead Sciences, Inc. GILD | NASDAQ
Company Overview:
10 Year Performance Metrics:
GILD Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
GILD Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
GILD Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
GILD Dividends Info:
GILD Dividend History: Dates, Payments & Yield list
Below is a schedule of all GILD dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 06/13/2025 | 06/27/2025 | $0.790 | 3.02% | 3.06% | $103.25 |
| 03/14/2025 | 03/28/2025 | $0.790 | 2.78% | 2.84% | $111.44 |
| 12/13/2024 | 12/30/2024 | $0.770 | 3.35% | 3.35% | $91.86 |
| 09/13/2024 | 09/27/2024 | $0.770 | 3.7% | 3.72% | $82.81 |
| 06/14/2024 | 06/27/2024 | $0.770 | 4.67% | 4.73% | $65.06 |
| 03/14/2024 | 03/28/2024 | $0.770 | 4.07% | 4.15% | $74.21 |
| 12/14/2023 | 12/28/2023 | $0.750 | 3.67% | 3.67% | $81.78 |
| 09/14/2023 | 09/28/2023 | $0.750 | 3.85% | 3.88% | $77.36 |
| 06/14/2023 | 06/29/2023 | $0.750 | 3.8% | 3.85% | $77.95 |
| 03/14/2023 | 03/30/2023 | $0.750 | 3.69% | 3.76% | $79.77 |
| 12/14/2022 | 12/29/2022 | $0.730 | 3.3% | 3.3% | $88.40 |
| 09/14/2022 | 09/29/2022 | $0.730 | 4.45% | 4.48% | $65.18 |
| 06/14/2022 | 06/29/2022 | $0.730 | 4.98% | 5.05% | $57.79 |
| 03/14/2022 | 03/30/2022 | $0.730 | 4.92% | 5.02% | $58.15 |
| 12/14/2021 | 12/30/2021 | $0.710 | 4.03% | 4.03% | $70.52 |
| 09/14/2021 | 09/29/2021 | $0.710 | 3.99% | 4.03% | $70.45 |
| 06/14/2021 | 06/29/2021 | $0.710 | 4.08% | 4.17% | $68.15 |
| 03/12/2021 | 03/30/2021 | $0.710 | 4.47% | 4.61% | $61.56 |
| 12/14/2020 | 12/30/2020 | $0.680 | 4.55% | 4.55% | $59.84 |
| 09/14/2020 | 09/29/2020 | $0.680 | 4.02% | 4.1% | $66.34 |
| 06/11/2020 | 06/29/2020 | $0.680 | 3.6% | 3.73% | $72.84 |
| 03/12/2020 | 03/30/2020 | $0.680 | 3.75% | 3.97% | $68.58 |
| 12/12/2019 | 12/30/2019 | $0.630 | 3.73% | 3.73% | $67.63 |
| 09/12/2019 | 09/27/2019 | $0.630 | 3.71% | 3.8% | $66.36 |
| 06/13/2019 | 06/27/2019 | $0.630 | 3.58% | 3.76% | $66.99 |
| 03/14/2019 | 03/28/2019 | $0.630 | 3.61% | 3.89% | $64.79 |
| 12/13/2018 | 12/28/2018 | $0.570 | 3.39% | 3.39% | $67.35 |
| 09/13/2018 | 09/27/2018 | $0.570 | 3.01% | 3.08% | $74.12 |
| 06/14/2018 | 06/28/2018 | $0.570 | 3.06% | 3.2% | $71.15 |
| 03/15/2018 | 03/29/2018 | $0.570 | 2.68% | 2.87% | $79.51 |
| 12/14/2017 | 12/28/2017 | $0.520 | 2.8% | 2.8% | $74.34 |
| 09/14/2017 | 09/28/2017 | $0.520 | 2.47% | 2.53% | $82.29 |
| 06/14/2017 | 06/29/2017 | $0.520 | 3.05% | 3.2% | $64.99 |
| 03/14/2017 | 03/30/2017 | $0.520 | 2.85% | 3.07% | $67.77 |
| 12/13/2016 | 12/29/2016 | $0.470 | 2.46% | 2.51% | $74.84 |
| 09/14/2016 | 09/29/2016 | $0.470 | 2.32% | 2.42% | $77.62 |
| 06/14/2016 | 06/29/2016 | $0.470 | 2.11% | 2.25% | $83.57 |
| 03/14/2016 | 03/30/2016 | $0.430 | 1.9% | 1.9% | $90.46 |
| 12/14/2015 | 12/30/2015 | $0.430 | 1.28% | 1.71% | $100.49 |
| 09/14/2015 | 09/29/2015 | $0.430 | 0.79% | 1.57% | $109.35 |
| 06/12/2015 | 06/29/2015 | $0.430 | 0.37% | 1.46% | $117.66 |
Projected Future Returns & Dividends for GILD
Based on past 10-year performance, here are GILD growth metrics:
Share price CAGR of -0.17%
Dividend CAGR of +6.27%
Using GILD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| GILD (DRIP) | GILD - No DRIP | |
|---|---|---|
| Current Price | $103.25 | $103.25 |
| Start Shares | 96.85 | 96.85 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 145.93 | 96.85 |
| Dividends Payment | $1.45 | $1.45 |
| Annual Dividends | $847 | $562 |
| Yield on cost | 8.47% | 5.62% |
| Share Price | $101.69 | $101.69 |
| Total Dividends | $5,022 | $4,086 |
| Final Value | $14,840 | $13,935 |
NOTE: Above numbers are our estimate based on GILD's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
Gilead Sciences, Inc. (GILD) had its IPO on 1992-01-22, and is trader on NASDAQ stock exchange.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
GILD website: https://www.gilead.com
